Caris Life Sciences (CAI) Change in Account Payables (2024 - 2026)

Caris Life Sciences' Change in Account Payables history runs 3 years deep, the most recent figure standing at $16.4 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 1041.4% year-over-year to $16.4 million; the TTM figure through Mar 2026 stood at $29.1 million (changed N/A YoY), while the FY2025 annual figure was $11.0 million, up 4982.74% from the prior year.
• Change in Account Payables for Q1 2026 stood at $16.4 million, up from $12.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $16.4 million in Q1 2026, with the low at -$5.3 million in Q4 2024.
• The 3-year median for Change in Account Payables is $729000.0 (2025), against an average of $3.5 million.
• The sharpest annual moves came in 2025 and 2026: Change in Account Payables sank 70.01% in 2025, then surged 1041.4% in 2026.
• Caris Life Sciences' Change in Account Payables stood at -$5.3 million in 2024, then soared by 331.65% to $12.2 million in 2025, then jumped by 33.85% to $16.4 million in 2026.
• Business Quant data shows CAI's Change in Account Payables at $16.4 million in Q1 2026, $12.2 million in Q4 2025, and $729000.0 in Q3 2025.